Immunome, Inc. · NASDAQ:IMNM
Barchas Isaac sold 201,050 Immunome, Inc. shares (Form 4)
Traded Jun 30 to Jul 2, 2026 · Filed Jul 2, 2026
From Jun 30 to Jul 2, 2026, Barchas Isaac (Director) sold 201,050 Immunome, Inc. shares at an average US$21.85 for US$4.39M under a trading plan, leaving 208,504 shares. Filed Jul 2, 2026 (Form 4).
- Sold
- 201,050 shares
- Price
- US$21.85 average (US$21.12 to US$23.33)
- Value
- US$4.39M
- Holding after
- 208,504 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Sale | 101,050 | US$21.12 | 308,504 | Indirect |
| Jul 2, 2026 | Common Stock | Sale | 75,665 | US$22.35 | 232,839 | Indirect |
| Jul 2, 2026 | Common Stock | Sale | 24,335 | US$23.33 | 208,504 | Indirect |
Source
Related
- Immunome, Inc.
- Barchas Isaac
- Immunome, Inc. shareholders
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026
- Form 4 · Barchas Isaac · Jul 7, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Horn Kinney · Aug 6, 2026
- Form 4 · Horn Kinney · Jul 27, 2026